RELEVARE PHARMACEUTICALS INC — Form D
RELEVARE PHARMACEUTICALS INC of BRISBANE QUEENLAND, C3, a company, filed a Form D exempt-offering notice with the SEC on 2010-04-20. The offering totals $3.2M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-04-20
- Form: D
- Accession: 0001455487-10-000004
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $3.2M
- Amount sold: $3.0M
- Remaining: $121K
- Investors: 3
- Date of first sale: 2010-03-15
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-140870
Issuer
- Name: RELEVARE PHARMACEUTICALS INC
- CIK: 0001455487
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: LEVEL 5 CENTRAL PLAZA 2, BRISBANE QUEENLAND, C3, 4001
- Phone: 61730096850
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Mark Blumling | Director | Brooklyn, NY |
| Andy Gearing | Director | San Francisco, CA |
| Ross Macdonald | Director | San Francisco, CA |
| Mark Blumling | Executive Officer | Brooklyn, NY |
| Matthew Morgan | Director | PORTLAND, OR |
| ANDREW HARPUR MICHELL | Director | BRISBANE, QLD, C3 |
Other filings by this issuer (3)
More